default author photo

Giandomenico Roviello

University of Florence - Department of Health Sciences

Firenze

Italy

SCHOLARLY PAPERS

3

DOWNLOADS

311

TOTAL CITATIONS

0

Scholarly Papers (3)

1.

Safety and Efficacy of Immune Checkpoint Inhibitors in Patients with Advanced Penile Squamous Cell Carcinoma: An International Study from the Global Society of Rare Genitourinary Tumors

Number of pages: 21 Posted: 31 Mar 2023
Harvard University - Lank Center for Genitourinary Oncology, Yale University - Yale New Haven Hospital (YNHH), McMaster University, Emory University - School of Medicine, Emory University School of Medicine - Department of Urology, Emory University - Department of Hematology and Medical Oncology, New York University (NYU) - Grossman School of Medicine, Government of the United States of America - National Cancer Institute, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Arkansas for Medical Sciences, University of Texas at Houston - Department of Melanoma Medical Oncology, Gustave Roussy, Gustave Roussy, University of Parma, Istituto Oncologico Veneto – IRCCS, Ohio State University (OSU) - Comprehensive Cancer Center, Ohio State University (OSU) - The James Comprehensive Cancer Center, Ohio State University (OSU) - The James Comprehensive Cancer Center, Hospital Universitario 12 de Octubre, Hospital Universitario 12 de Octubre, Hospital Universitario 12 de Octubre, University of Florence - Department of Health Sciences, Careggi University Hospital of Florence - Clinical Oncology Unit, University of California, San Diego (UCSD) - Moores Cancer Center, University Campus Bio-Medico, Imperial College London - Hammersmith Hospital, University of California, University of California, Stanford University, Stanford University, Mayo Clinic - Department of Cardiovascular Medicine, Indiana University Purdue University Indianapolis (IUPUI) - Indiana University School of Medicine, Mount Sinai Health System - Division of Hematology and Medical Oncology, Mount Sinai Health System - Icahn School of Medicine, Hospital de la Santa Creu i Sant Pau - Medical Oncology Department, Università degli Studi di Bari “Aldo Moro” (UNIBA), Vanderbilt University - Vanderbilt-Ingram Cancer Center, Duke University - Duke University Hospital, Duke University - Duke University Hospital, National Cancer Centre Singapore, University of Parma, Ruhr University of Bochum - University Hospitals, IRCCS Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" (IRST) - Clinical and Experimental Oncology Unit, University of Ulsan - Asan Medical Center, University of North Carolina (UNC) at Chapel Hill - Lineberger Comprehensive Cancer Center, University of Pittsburgh - Division of Hematology/Oncology, University of Pittsburgh - Division of Hematology/Oncology, Yale University - Yale New Haven Children's Hospital, Harvard University - Dana-Farber Cancer Institute, Harvard University - Lank Center for Genitourinary Oncology, H. Lee Moffitt Cancer Center and Research Institute, Università Vita-Salute San Raffaele - IRCCS San Raffaele Scientific Institute, National Institutes of Health (NIH) - Bladder Cancer Section and Advent Health Cancer Institute - Division of Medical Oncology
Downloads 245 (311,323)

Abstract:

Loading...

penile cancer, immune checkpoint inhibitors, international cohort, rare disease

2.

Ivosidenib in IDH1-Mutated Cholangiocarcinoma: Clinical Evaluation and Future Directions

Number of pages: 22 Posted: 04 Dec 2021
Careggi University Hospital of Florence - Clinical Oncology Unit, Careggi University Hospital of Florence - Clinical Oncology Unit, Careggi University Hospital of Florence - Medical Oncology Unit, Careggi University Hospital of Florence - Medical Oncology Unit, Careggi University Hospital of Florence - Medical Oncology Unit, Careggi University Hospital of Florence - Medical Oncology Unit, Careggi University Hospital of Florence - Medical Oncology Unit, University of Florence - Department of Health Sciences, Careggi University Hospital of Florence - Medical Oncology Unit and Careggi University Hospital of Florence - Clinical Oncology Unit
Downloads 66 (907,769)

Abstract:

Loading...

Cholangiocarcinoma, IDH1, D-2-hydroxyglutarate, ClarIDHy

3.

Measuring Taste Alterations in Cancer Patients Undergoing Chemotherapy or Target Therapy

15TH PANGBORN SENSORY SCIENCE SYMPOSIUM - MEETING NEW CHALLENGES IN A CHANGING WORLD (PSSS 2023):I01
Posted: 24 Aug 2023
University of Florence, University of Florence, University of Florence, University of Florence, University of Florence, University of Florence, University of Florence, University of Florence, University of Florence, University of Florence and University of Florence - Department of Health Sciences

Abstract:

Loading...